2018 – Frontiers in Immunology: The Long Pentraxin 3 Plays a Role in Bone Turnover and Repair (Sironi
M., Deban L., Inforzato A., Mantovani A., Bottazzi B., Valentino S.)

2019 – Frontiers in Immunology: The Long Pentraxin PTX3 in Bone Homeostasis and Pathology
(Parente R., Sobacchi C., Bottazzi B., Mantovani A., Groevic D., Inforzato A.)

2019 – The Association for the Publication of the Journal of Internal Medicine: Innate immunity,
inflammation and tumour progression: double-edged swords (Mantovani A., Ponzetta A., Inforzato A.,
Jaillon S.)

2019 – Frontiers in Immunology: The Long Pentraxin PTX3 as a Link Between Innate lmmunity, Tissue
Remodeling, and Cancer (Doni A., Stravalaci M., Inforzato A., Magrini E., Mantovani A., Garlanda C.,
Bottazzi B.)

2020 – International Journal of Molecular Sciences: DNA Damage Response and Immune Defense (Nastasi
C., Mannarino L., D’Incalci M.)

2020 – The American Physiological Society: Thrombospondins in bone remodeling and metastatic bone
diseasee (Carminati L., Taraboletti G.)

2020 – Frontiers in Immunology: Innate immunology in the context of osteoimmunology (Sobacchi C.,
Ignatius A.)

2020 – FEBS Letters: The complement system in Aspergillus fumigatus infections and its
crosstalk with pentraxins (Parente R, Doni A, Bottazzi B, Garlanda C, Inforzato A.)

2020 – Frontiers in Pharmacology: Control of Complement Activation by the Long Pentraxin PTX3:
lmplications in Age-Related Macular Degeneration (Stravalaci M., Davi F., Parente R., Gobbi M., Bottazzi
B., Mantovani A., Romano M., Inforzato A.)

2021 – Frontiers in Immunology – Complementary Roles of Short and Long Pentraxins in the
Complement-Mediated Immune Response to Aspergillus fumigatus lnfections (Parente R., possetti V.,
Erreni M., D’Autilia F., Bottazzi B., Garlanda C., Manovani A., Inforzato A., Doni A.)

2021 – Pathongens – 3D Cocultures of Osteoblasts and Staphylococcus aureus on Biomimetic
Bone Scaffolds as a Tool to Investigate the Host-Pathogen Interface in Osteomyelitis (Parente R.,
Possetti V., Schiavone M.L., Campodoni E., Menale C., Loppini M., Doni A., Bottazzi B., Mantovani
A., Sandri M., Tampieri A., Sobacci C., Inforzato A.)

2022 – Frontiers in Pharmacology – The Long Pentraxin PTX3 as a New Biomarker and
Pharmacological Target in Age-Related Macular Degeneration and Diabetic Retinopathy (Stravalaci M.,
Ferrara M., Davi F., Bottazzi B., Mantovani A., Romano M., Inforzato A.)

2022 – Frontiers in Immunology – Bone Marrow Niches and Tumour Cells: Lights and Shadows of a
Mutual Relationship (Granta V., Crisafulli L. Nastasi C., Ficara F., Sobacchi C.)

2022 – Frontiers in Immunology – The Osteoblast Secretome in Staphylococcus Aureus Osteomyelitis
(Granata V., Possetti V., Parente R., Bottazzi B., Inforzato A., Sobacci C.)

2023 – Frontiers in Immunology: Regulation of osteoclast differentiation in
autoimmune and inflammatory diseases (Sun-Kyeong Lee, Antonio Inforzato, Cristina Sobacchi)

2023 – Journal of Clinical Medicine: Long Pentraxin 3 as a new Biomarker for
Diagnosis of Hip and Knee Periprosthetic Joint Infections (Mattia Loppini, Marco Di Maio, Roberta
Avigni, Roberto Leone, Antonio Inforzato, Guido Grappiolo, Alberto Mantovani, Barbara Bottazzi)

2023 – eLife: Regulation of inflammation and protection against invasive
pneumococcal infection by the long pentaxin PTX3 (Raffaella Parente, Sonia Valentino, Andrea
Doni, Antonio Inforzato, Barbara Bottazzi, Alberto Mantovani)

2023 – Frontiers in Immunology: Structural insights into the biological functions of the
long pentraxin in PTX3 (Anna Margherita Massimino, Filippo Emanuele Colella, Barbara Bottazzi,
Antonio Inforzato)

2023 – International Journal of Molecular Sciences: Genetic Deficiency of the Long
Pentraxin 3 Affects Osteogenesis and Osteoclastogenesis in Homeostatic and Inflammatory
Conditions (Valentina Granata, Dario Strina, Maria Lucia Schiavone, Barbara Bottazzi, Alberto
Mantovani, Antonio Inforzato, Cristina Sobacchi)

2023 – Seminars in Cell and Developmental Biology: Thrombospondin-1 in drug
activity and tumor response to therapies (Elisa Longhi, Laura Carminati, Elena Carlessi, Dorina
Bellotti, Giulia Taraboletti)

2023 – Matrix Biology: Controlled extracellular proteolysis of thrombospondins (Elisa
Longhi, Laura Carminati, Elena Carlessi, Giulia Taraboletti)

2024 – Interleukin-1β Polymorphisms Are Genetic Markers of Susceptibility to Periprosthetic Joint Infection in Total Hip and Knee Arthroplasty
(Valentina Granata, Dario Strina, Valentina Possetti, Roberto Leone,Sonia Valentino,Katia Chiappetta, Mattia Loppini, Alberto Mantovani, Barbara Bottazzi, Rosanna Asselta, Cristina Sobacchi).

2024 – Rankl genetic deficiency and functional blockade undermine skeletal stem and progenitor cell differentiation
(M.L. Schiavone, L. Crisafulli, C. Camisaschi, G. De Simone, F. R. Liberati, E. Palagano, N. Rucci, F. Ficara, C. Sobacchi).

2024 – Two different responsive organosilica nanocarriers to combine chemo- and immunotherapy against cancer
(Maria Sancho-Albero, Alessia Lucrezia Fenaroli, Mirco Scaccaglia, Cristina Matteo, Chiara Grasselli, Massimo Zucchetti, Roberta Frapolli, Claudia Nastasi, Luisa De Cola).

2024 – Advanced Targeting Systems for Tissue-Specific Drug Delivery (Claudia Nastasi).

2024 – Host genetics and gut microbiota influence lipid metabolism and inflammation: potential implications for ALS pathophysiology in SOD1G93A mice
(Elena Niccolai, Leandro Di Gloria, Maria Chiara Trolese, Paola Fabbrizio, Simone Baldi, Giulia Nannini, Cassandra Margotta, Claudia Nastasi, Matteo Ramazzotti, Gianluca Bartolucci, Caterina Bendotti, Giovanni Nardo3, Amedeo Amdei).

2024 – Thrombospondin-1 in drug activity and tumor response to therapies
(Elisa Longhi, Laura Carminati, Elena Carlessi, Dorina Belotti, Giulia Taraboletti)